Suchergebnisse - "BRCA2 protein, human"

PubPharm (3.314)

1

Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health

enthalten in: BMC genomics | 2024

von Andaluz, S. | Zhao, B. | Sinha, S. | +5

2

The frequency and pathogenicity of BRCA1 and BRCA2 variants in the general Japanese population

enthalten in: Journal of human genetics | 2024

von Idogawa, M. | Mariya, T. | Tanaka, Y. | +4

ErratumIn: J Hum Genet. 2024 Mar 14;:. - PMID 38480854

3

A glycolytic metabolite bypasses "two-hit" tumor suppression by BRCA2

enthalten in: Cell | 2024

von Kong, L. | Gupta, K. | Wu, A. | +22

4

A glycolytic metabolite that drives BRCA2 haploinsufficiency

enthalten in: Cell | 2024

von Jiang, P.

5

Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer-Development of Recommendations for Optimal Assay Performance

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2024

von Romey, M. | Rodepeter, F. | Hattesohl, A. | +13

6

Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer : Mastectomy versus conservative treatment

enthalten in: Journal of gynecology obstetrics and human reproduction | 2024

von Mahiou, K. | Jankowski, C. | Vincent, L. | +5

7

Clinical implications of VUS reclassification in a single-centre series from application of ACMG/AMP classification rules specified for BRCA1/2

enthalten in: Journal of medical genetics | 2024

von Innella, G. | Ferrari, S. | Miccoli, S. | +5

8

Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System

enthalten in: BMC cancer | 2024

von de Oliveira Ferreira, C. | Carneiro, V. | Araujo Mariz, C.

9

Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer-Associated Germline Pathogenic Variants in Mexico

enthalten in: JCO global oncology | 2024

von Mesa-Chavez, F. | Chavarri-Guerra, Y. | Aguilar-Y-Mendez, D. | +12

10

Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Harvey-Jones, E. | Raghunandan, M. | Robbez-Masson, L. | +36

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[332]